Where does Exsurco Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Exsurco Medical, Inc. ranks #22,560 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Exsurco Medical, Inc. hold?

Exsurco Medical, Inc. holds 12 US utility patents granted between 2015 and 2025, spanning 5 technology areas.

What is Exsurco Medical, Inc.'s Innovation Score?

Exsurco Medical, Inc. has an Innovation Score of 33.7 out of 100 (45th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Exsurco Medical, Inc. focus on?

Exsurco Medical, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 8 patents, ranking #2,086 of 7,127 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Exsurco Medical, Inc.'s patent grant rate increasing or decreasing?

Exsurco Medical, Inc.'s recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Exsurco Medical, Inc.'s patents?

Exsurco Medical, Inc.'s patents average 17.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Exsurco Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Exsurco Medical, Inc.

USPTO PatentsView assignee record - 12 granted patents across 5 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Exsurco ranks #22,560 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 5 technology areas.

#22,560
of 49,997 US assignees by volume: 45th percentile
by Innovation Score (33.7/100): 17.1
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22560 · US Corporation #22,560 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #22,560/49,997
PHOTO-FINISH Excelerate Energy…
CPC-NARROW A61B · 5 areas
INNOV-THIN 33.7/100
CLAIMS-RICH 17.1 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Excelerate Energy Limited Partnership (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Exsurco’s 33.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (26%) Velocity 6.7 pts (20%) Breadth 7.9 pts (23%) Claim depth 10.2 pts (30%)

Qualcomm Incorporated · highest

85
Celagenex Research… · near

34
Exsurco Medical · this assignee

34
Hermes-Epitek · near

34
Nerudia · near

34
Tenacious Holdings · near

34
3D Lighting… · lowest

7

What this shows Exsurco's Innovation Score is 33.7/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Exsurco?

Each dot is one of Exsurco’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Exsurco’s own 17.1 claims/patent is ABOVE the 14.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Exsurco vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Exsurco's grants concentrate

Exsurco Medical, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 66.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2015. By volume, Exsurco sits between Excelerate Energy Limited Partnership and Fadu Inc..

Exsurco's three-year grant acceleration

Exsurco Medical, Inc. shows 3 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Excelerate Energy…

12
Exordium Engineer…

12
Exosect

12
Expander Energy

12
Extend Biosciences

12
Faber-castell

12
Faculty Physician…

12
Fadu

12
Exsurco Medical ◀

12

What this shows Exsurco holds 12 patents at rank #22,558, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Exsurco

By rank, the assignees closest to #22,558 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Exsurco's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Exsurco, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Exsurco ranks #2,086 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

Celagenex Research (INDIA) PVT. Ltd. 34 Hermes-Epitek Corporation 34 Nerudia Limited 34 Tenacious Holdings, Inc. 34

Exsurco's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Exsurco Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	8.3%
2017	1	8.3%
2018	2	16.7%
2020	1	8.3%
2021	2	16.7%
2022	2	16.7%
2023	1	8.3%
2025partial year	2	16.7%

Which technologies does Exsurco Medical, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 8

B23P - Metal-working NOT Otherwise Provided FOR; Combined OPERATIONS; Universal Machine Tools 3

B23B - TURNING; Boring 2

B26B - Hand-held Cutting Tools NOT Otherwise Provided FOR 1

A22B - Slaughtering 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Exsurco Medical, Inc.'s patent record in context - here's where to go next.

Exsurco Medical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 66.7% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #22,560 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Exsurco Medical, Inc. against Excelerate Energy Limited Partnership, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.